Comparison of Screening Guidelines for Cardiovascular disease Prevention and Early Detection:a scoping review

Author:

Darwesh Badawy Mohammed Abd ElFattah MohammedORCID,Naing LinORCID,Tuah Nik Ani AfiqahORCID

Abstract

ABSTRACTObjectiveGlobally, cardiovascular disease (CVD) has a significant role in morbidity and early death. This review’s objective is to provide a summary of the strengths and weaknesses in the variety of screening guidelines made by several international organizations for the early identification and prevention of CVD.MethodsAs the reporting guideline for this review, we used Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). We performed a scoping review using a few guideline-specific databases. We tabulated the main key differences between the included screening guidelines for CVD prevention and early detection from different perspectives.ResultsWe included a total of 20 unique guidelines that were developed by various organizations throughout the world and focused on screening for CVD prevention and early detection out of the 2,466 guidelines discovered by our search based on our eligibility criteria. We concluded that the target populations, CVD risk assessment techniques, outcomes, and categories of the chosen CVD prevention guidelines widely varied. Additionally, some guidelines adopted no grading scheme for their evidence, while others did not advocate the use of any imaging screening tools in their evaluation of the CVD risk.ConclusionsThis scoping review highlights the areas of each guideline’s strengths and weaknesses and conducts a systematic comparison of a number of worldwide guidelines for CVD prevention and early diagnosis.What is already known in this review?Based on the most recent evidence and consensus among experts, each nation creates its own set of guidelines for the early detection and prevention of CVD.What this review addsThis review conducted a systematic comparison and summarized the strengths and weaknesses of the various screening guidelines made by numerous international organizations for the early detection and prevention of CVD.• How this review might affect research, practice or policyThis review provided opportunities to improve the future development of the clinical practice guidelines for CVD prevention and early detection.

Publisher

Cold Spring Harbor Laboratory

Reference43 articles.

1. Roth GA , Mensah GA , Johnson CO , Addolorato G , Ammirati E , Baddour LM , et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J. Am. Coll. Cardiol. Elsevier Inc.; 2020. p. 2982–3021.

2. Nelson S , Whitsel L , Khavjou O , Phelps D , Leib A . Projections of cardiovascular disease prevalence and costs. RTI Int, Res Triangle Park NC, USA, Tech Rep. 2016;214680.

3. Sjögren B , Bigert C , Gustavsson P. Chapter 16 – Cardiovascular Disease. In: Nordberg GF, Fowler BA, Nordberg MBT-H on the T of M (Fourth E, editors. San Diego: Academic Press; 2015. p. 313–31. Available from: https://www.sciencedirect.com/science/article/pii/B9780444594532000160

4. World Health Organization . Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk. World Health Organization; 2007.

5. European Guidelines on cardiovascular disease prevention in clinical practice;Eur Heart J,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3